؉ 
T he adoptive transfer of CD4
ϩ CD3 ϩ T cells into congenic, immunodeficient hosts induces an inflammatory bowel disease (IBD), 3 the major manifestation of which is a severe pancolitis. This has been demonstrated in H-2 d mice of the BALB/c background (1) (2) (3) (4) (5) and in H-2 b mice of the C57BL/6 (B6) background (6 -8) . The key factors for the development of an IBD in these models are an inducing CD3 ϩ
CD4
ϩ ␣␤ T cell subset, a congenic, severely immunodeficient host, and an intact gut flora of the host. A defect in the immunoregulation of mucosal T cell responses is supposed to play a key role in the pathogenesis of colitis in these models, with exaggerated IFN-␥ and TNF-␣ responses as major mediators of this disease (reviewed in (9, 10) . These pathogenic T cell responses may be driven by Ags of the intestinal flora to which these T cells are normally tolerant. In the host developing colitis, neither the inducing CD4 ϩ T cell subset nor the stimulus that drives the Th1-biased T cell activation in the mucosa has been identified. Splenic CD4 ϩ T cells with a CD45RB high surface phenotype have an enhanced IBD-inducing potential in H-2 d C.B-17 scid/scid (SCID) mice (reviewed in Ref. 11) . It is unresolved which IBD-inducing CD4 ϩ T cell subset(s) the CD45RB high surface phenotype identifies, and it has been shown that CD45RB high as well as CD45RB low CD4 ϩ T cell can induce a colitis in this adoptive transfer system (8, 12) . IBD-associated effector T cell populations accumulating in the inflamed colonic lamina propria (cLP) in different mouse models can be conventional CD4 ϩ ␣␤ ϩ T cells, ␣␤ ϩ and ␥␦ ϩ T cells (13) , CD8 ϩ ␣␤ ϩ T cells (14) , or unusual TCR␣ Ϫ ␤ ϩ T cells (15) . Key questions of the pathogenesis of T cell-induced IBD are unresolved. Preclinical mouse models offer an attractive approach to clarify some aspects of these common and debilitating diseases that may pave the way for the rational design of novel therapeutic approaches.
Development of epitope recognition of most CD4 ϩ ␣␤ T cells is MHC-II-dependent. A small subset of MHC-II-independent CD4 ϩ ␣␤ T cells is present in normal and MHC-II-deficient (A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ knockout (KO)) mice. MHC-II-independent CD4 ϩ ␣␤ T cells in A␤ Ϫ/Ϫ mice are thymically derived, appear early in ontogeny, localize preferentially to the B rather than to the T cell areas in peripheral lymphoid organs, exhibit the phenotype of resting or activated memory T cells, and have a diverse TCR␣␤ repertoire that is potentially functional (16, 17) . These T cell populations are heterogeneous with respect to phenotype, array of peptides and/or glycolipids recognized, and restriction elements used for specific recognition (18 -22) . Only one subset within the MHC-II-independent CD4 ϩ T cells, i.e., CD1d-restricted NK1 ϩ T cells expressing the NK1 marker (NKT) cells is well defined (reviewed in Refs. 23 and 24) . NKT cells express the semi-invariant V␣14J␣281 V␤8.2 TCR, bear the NK1.1 marker (in appropriate mouse strains), are found mainly in thymus and liver, rapidly produce the cytokines IFN-␥ and IL-4 after stimulation, and recognize the glycolipid ␣-galactosyl ceramide (␣-GalCer) in the context of CD1d (17, (25) (26) (27) (28) (29) (30) (31) . MHC-II-independent, CD1d-restricted NKT cells are absent from CD1d Ϫ/Ϫ KO mice (32) (33) (34) . The presence and function of MHC-II-independent CD4 ϩ T cells in the gut is not clear. Although NK-like T cells have been found in the intraepithelial compartment of the small intestine of mice (35) , NK1 and lamina propria lymphocyte (LPL) populations (36) . Recently, CD1d-glycolipid tetramer staining has revealed NK1 Ϫ CD4 Ϫ CD8 Ϫ tetramer-positive T cells with the characteristic semi-invariant TCR in lymph nodes and the small intestine (22, 37, 38 hosts to test their IBD-inducing potential. Unexpectedly, the adoptively transferred MHC-II-independent CD4 ϩ T cells efficiently induced colitis. This observation points to a new feature of MHC-II-independent CD4 ϩ T cells, their potential to trigger inflammatory Th1-type reactions in the mucosa. 
Materials and Methods

Mice
Flow cytometry (FCM) analyses of the surface phenotype and intracellular cytokine expression
Cells were suspended in PBS/0.3% w/v BSA supplemented with 0.1% w/v sodium azide. Nonspecific binding of Abs to Fc receptor was blocked by preincubating cells with the mAb 2.4G2 directed against the Fc␥RIII/II CD16/CD32 (1 g mAb/10 6 cells/100 l). Cells were incubated with 0.5 g/10 6 cells of the relevant mAb for 30 min at 4°C and washed. In most experiments, cells were subsequently incubated with a second-step reagent for 10 min at 4°C. Three-color FCM analyses were performed on a FACSCalibur (BD Becton Dickinson, Mountain View, CA). The forward narrow angle light scatter was used as an additional parameter to facilitate exclusion of dead cells and aggregated cell clumps. The following reagents and mAb were obtained from BD PharMingen (Hamburg, Germany): PEconjugated anti-CD3⑀ mAb 145-2C11, FITC-and PE-conjugated anti-CD4 mAb GK1.5, biotinylated anti-CD4 mAb RM4-5, FITC-conjugated anti-CD8␣ mAb 53-6.7, biotinylated anti-CD44 (Pgp-1) mAb IM7, biotinylated anti-CD45RB mAb 23G2, biotinylated anti-CD28 mAb 37.51, biotinylated anti-CD69 mAb H1.2F3, PE-conjugated anti-NK1.1 mAb PK136, biotinylated anti-CD40L mAb MR1, and FITC-conjugated anti-CD62L (L-selectin) mAb MEL-14. PE-conjugated streptavidin was obtained from PharMingen. SA-Red670 was obtained from Life Technologies (Berlin, Germany). Cells (10 6 cells/ml) were stimulated with 50 ng/ml PMA and 500 ng/ml ionomycin in the presence of 10 g/ml brefeldin A in RPMI 1640/10% FCS for 12 h at 37°C with 5% CO 2 . Cells were harvested, washed twice in staining buffer (PBS without Mg 2ϩ /Ca 2ϩ , 0.3% w/v BSA, 0.1% w/v sodium azide), incubated (15 min, 4°C) with purified 2.4G2 Ab to block nonspecific binding of Ab to Fc receptors, washed with staining buffer, resuspended in staining buffer, and surface stained with the relevant Abs. Cells were washed with staining buffer, labeled with the second-step reagent, and washed twice. Cells were then resuspended in 100 l Cytofix/ Cytoperm solution for 20 min at 4°C and washed twice in 1 ml 1ϫ Perm/ Wash solution. Fixed and permeabilized cells were resuspended in 100 l of 1ϫ Perm/Wash solution. Cells were stained for 30 min at 4°C with 1 g mAb/10
6 cells of FITC-conjugated anti-IL-4 mAb BVD4-1D11, FITCconjugated anti-IL-10 mAb JES5-16E3, FITC-conjugated anti-TNF-␣ mAb MP6-XT22, FITC-conjugated anti-IFN-␥ mAb XMG1.2, or appropriate negative control Abs (FITC-conjugated rat IgG1 mAb R3-34; PEconjugated rat IgG1 mAb R3-34). Cells were washed twice in 1ϫ Perm/ Wash solution (250 ϫ g) and resuspended in staining buffer; 10 4 cells were analyzed by FCM using a FACScan equipped with a 15-mW argon laser (BD Becton Dickinson) using the CellQuest software (BD Becton Dickinson).
CD4
ϩ T cells used for adoptive transfer 
Isolation of lymphoid cell populations from transplanted mice
Transplanted RAG Ϫ mice were sacrificed by cervical dislocation. Single cell suspensions were aseptically prepared from the spleen, the mesenteric lymph nodes, and the lamina propria of the intestine. Colonic LPLs were isolated as described (12, 41, 42) .
Generation of myeloid dendritic cells (DC) from bone marrow
The in vitro generation of myeloid DC from murine bone marrow has been described (43) . Briefly, bone marrow cells prepared from femurs were depleted of CD4 ϩ CD8 ϩ B220 ϩ lymphocytes and MHC-class-II ϩ cells (Miltenyi Biotec) by MACS sorting. These bone marrow cells depleted of T cells, B cells, and maturing myeloid cells were cultured at a density of 10 6 cells/ml in 6-well plates (Nunc, Wiesbaden, Germany) in serum-free UltraCulture medium (BioWhittaker, Verviers, Belgium) supplemented with 5 ng/ml GM-CSF and 10 ng/ml FL (PeproTech, Rocky Hill, NJ), 2 mM glutamine, and antibiotics. Cultures were incubated at 37°C in humidified air supplemented with 5% CO 2 . On days 3 and 5, cells were fed by medium exchange. From day 7 of cultures, nonadherent CD11c ϩ cells were purified by magnetic bead separation (Miltenyi Biotec), pulsed with bacterial lysates, and used as stimulator cells for CD4 ϩ T cells.
Cytokine determination by ELISA
The release of cytokines by CD4 ϩ T cells was detected by a conventional double-sandwich ELISA. For detection and capture, the mAb R4-6A2 and biotinylated mAb AN18 were used for IFN-␥ (PharMingen). Extinction was analyzed at 405/490 nm on Spectra-Max equipment (Molecular Devices, Sunnyvale, CA) using the Softmax Pro software (Molecular Devices).
Histopathological examinations
Tissue samples were taken from various locations of the small and large intestine (duodenum, jejunum, terminal ileum, cecum, ascending colon, transverse colon, recto-sigmoid colon). Tissue was fixed in neutral buffered formalin, embedded in paraffin, sectioned on a microtome, mounted on slides, and stained with hematoxylin/eosin.
Results
Characterization of CD4 ϩ T cells found in normal, MHC-IIdeficient (A␣
We analyzed the surface phenotype, the inducible expression of proinflammatory cytokines, the response to ␣-GalCer, and the diversity of the TCR V␤ repertoire of CD4 ϩ T cells from the B6 lines that were used as donors in the adoptive transfer experiments described below. Approximately one-third of the mononuclear cells from the spleen or cLP from normal, MHC-II-deficient 
CD8
Ϫ or CD4
ϩ T cells showed an effector/memory T cell phenotype with high expression of costimulator molecules but also high CD45RB expression (data not shown).
Twice as many splenic CD4 ϩ T cells from MHC-II-deficient than from normal B6 mice produced high levels of TNF-␣ and/or IFN-␥ after a 12-h incubation with phorbol ester and ionomycin (Fig. 1A) . Splenic CD4 ϩ T cells from normal and MHC-II-deficient (A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ ) B6 mice proliferated and produced IFN-␥ in response to stimulation by Con A, anti-CD3⑀ Ab or ␣-GalCer; splenic CD4
ϩ T cells from MHC-I-deficient (␤ 2 m Ϫ/Ϫ , CD1d Ϫ/Ϫ ) B6 mice responded to polyclonal stimulation by Con A or anti-CD3⑀ Ab but not to stimulation by ␣-GalCer (Fig. 1B , and data not shown). cLP CD4 ϩ T cells from all lines released IFN-␥ in response to polyclonal T cell stimulation by Con A or anti-CD3⑀ Ab but did not respond to ␣-GalCer stimulation (Fig. 1B, and data not  shown) . The TCR V␤ repertoire of CD4 ϩ T cells from the spleen and the cLP of normal B6 or MHC-II-deficient A␤ Ϫ/Ϫ KO B6 mice was diverse (data not shown).
Transfer of MHC-II-dependent and -independent CD4 ϩ T cells induces a colitis in RAG1
Ϫ/Ϫ hosts When splenic CD4 ϩ T cells from either normal or MHC-II-deficient (A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ KO) B6 mice were injected into congenic RAG1 Ϫ/Ϫ B6 hosts (3 ϫ 10 5 cells/mouse), these mice showed diarrhea and rectal prolapse within 3-6 wk posttransfer ( Fig. 2A) . Many mice lost Ͼ20% of their body weight within 3-6 wk posttransfer. Loss in body weight did not strictly correlate with disease severity, because some transplanted mice died early posttransfer without significant loss of body weight, although they showed a histopathology of severe IBD. This IBD was progressive, severe, and always lethal. The course of the IBD in B6 RAG1
Ϫ/Ϫ hosts induced by the transfer of congenic CD4 ϩ T cells was more aggressive and showed less interindividual variability than did the IBD in SCID mice induced by the transfer of BALB/c-derived CD4 ϩ T cells that we have described in detail previously (12 and A␤ Ϫ/Ϫ KO B6 donor mice were equally efficient in inducing IBD (data not shown). These data reveal a new feature of MHC-II-independent CD4 ϩ T cells: their unexpected efficiency in inducing mucosal inflammation.
The histopathology revealed a severe IBD that was limited to the colon. The small intestine was involved only rarely, and if so, showed a generally mild inflammation confined to the proximal jejunal region and the duodenum. In all locations of the large intestine, an inflammatory infiltrate of varying intensity was present. As a rule, the intensity of inflammation was high in the cecum, declined toward the transverse part of the colon to reincrease again in the recto-sigmoid. The inflammatory changes showed a patchy distribution pattern, with severely inflamed mucosal areas adjacent to only mildly affected areas. The inflammatory infiltrate consisted of mononuclear leukocytes with a variable portion of neutrophils. The histopathological changes ranged from crypt hyperplasia with mucosal thickening, a mild depletion of goblet cells, and a predominant mononuclear infiltrate in areas of mild inflammation (Fig. 3, A and F) to severe colitis with erosions, crypt abscesses, mucosal atrophy, and disorganization of the cryptal architecture, an almost complete loss of goblet cells in conjunction with large numbers of granulocytes (Fig. 3, B-D) . Streams of mucus admixed with pus and exfoliated epithelial cells often covered the luminal surface of severely inflamed regions (Fig. 3, C and D) . The leukocyte infiltrate was confined to the mucosal layer. Occasional infiltrates into the adjacent submucosa were seen in areas of erosions or ulcerations. Crypt abscesses were frequently found in areas of severe inflammation. This IBD arising in transplanted RAG Ϫ/Ϫ hosts in the complete absence of B cells and MHC-II-dependent CD4
ϩ T cells resembled in type, intensity, and distribution the IBD that we have described previously in C.B.-17 scid/scid mice transplanted with BALB/c-derived CD4 ϩ T cells (12, 42) .
Surface phenotype and cytokine expression of IBD-associated, cLP CD4 ϩ T cells derived from MHC-II-competent or MHC-IIdeficient donor mice
We isolated cLP T cells from RAG1 Ϫ/Ϫ mice with severe IBD that were transplanted with splenic CD4 ϩ T cells from MHC-II-dependent or -independent B6 donor mice. The phenotype of IBD-associated cLP CD4
ϩ T cells indicated that they are activated in situ evident by low expression of CD62L and high expression of CD69 ϩ T cell populations because differences were apparent in the surface phenotype of cLP NK1 ϩ vs NK1 Ϫ CD4 ϩ T cells (Fig.  4) . cLP NK1 ϩ CD4 ϩ T cells from diseased RAG Ϫ/Ϫ hosts expressed higher surface levels of CD45RB than did NK1
Ϫ CD4 ϩ T cell in the same LPL population. Surface expression of CD28 was higher in NK1 ϩ CD4 ϩ T cells than in NK1 Ϫ CD4 ϩ T cells. Expression of CD40L was low in NK1 ϩ and NK1 Ϫ CD4 ϩ T cells. Cytoplasmic staining of cLP CD3 ϩ CD4 ϩ T cells from transplanted RAG Ϫ/Ϫ mice with IBD for cytokines showed that 10 -25% of these cells produced high levels of the proinflammatory cytokines TNF-␣ and IFN-␥ (Fig. 5) . Few IL-4-or IL-10-producing T cells were found in cLP CD4 ϩ T cell populations from transplanted RAG Ϫ/Ϫ mice with IBD (Fig. 5) . In diseased RAG Ϫ/Ϫ mice, a larger fraction of the cLP CD4 ϩ T cells from A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ B6 mice expressed these two potent proinflammatory cytokines than did cLP CD4 ϩ T cells from normal B6 donor mice. This may be related to the more aggressive course of colitis seen after transfer of MHC-II-independent CD4 ϩ T cells, despite the observation that lower numbers of cLP CD4 ϩ T cells were recovered from the cLP of diseased RAG Ϫ/Ϫ mice transplanted with A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ B6 donor-derived T cells than in those transplanted with CD4 ϩ T cells from normal B6 donor mice. cLP and splenic CD4 ϩ T cells from MHC-II-competent or MHC-II-deficient (A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ ) donor mice engrafted in diseased RAG1 Ϫ/Ϫ mice released IFN-␥ in response to polyclonal T cell activation (by Con A or anti-CD3⑀ mAb) but not to ␣-GalCer (data not shown). The analysis of the TCR V␤ repertoire of CD4 ϩ T cells isolated from the cLP of individual transplanted RAG Ϫ/Ϫ mice with colitis indicated that cLP CD4 ϩ T cell populations derived from normal B6 donor mice always had a polyclonal TCR V␤ repertoire. In contrast, three of five analyzed RAG Ϫ/Ϫ mice transplanted with CD4 ϩ T cells from A␤ Ϫ/Ϫ B6 donor mice showed a preferential usage of TCR V␤5, indicating an oligoclonal TCR V␤␤ repertoire of the disease-associated cLP CD4 ϩ T cells (data not shown).
We tested whether ligand recognition of IBD-associated cLP CD4 ϩ T cells from normal B6 or MHC-II-deficient (A␤ Ϫ ) B6 donor mice is MHC-I-or MHC-II-dependent. Myeloid DC grown from bone marrow in GM-CSF/FL-supplemented, serum-free cultures were used as stimulator cells. These presenting cells were pulsed with bacterial lysates derived from diseased RAG Ϫ/Ϫ mice as described (44, 45) . The data in Fig. 6A show that CD4 ϩ T cells from normal B6 mice isolated from the cLP of transplanted RAG Ϫ/Ϫ hosts with IBD released IFN-␥ when restimulated with syngeneic (MHC-I-and MHC-II-expressing), lysate-pulsed but not nonpulsed DC. This response was MHC-II restricted because it was completely blocked by an anti-A b mAb. CD4 ϩ T cells from A␤ Ϫ/Ϫ B6 mice obtained from the cLP of diseased, transplanted RAG Ϫ/Ϫ hosts released IFN-␥ when restimulated with syngeneic normal or MHC-II-deficient, lysate-pulsed DC (Fig. 6B) . At least part of this response was MHC-I-dependent because these cLP T cells released 4 -10 times less IFN-␥ when stimulated with MHC-I-deficient, lysate-pulsed DC from ␤ 2 m Ϫ/Ϫ KO B6 mice (Fig. 6B ). These data indicate that IBD-associated cLP CD4 ϩ T cells from normal B6 donor mice show MHC-II-dependent reactivity, whereas those from A␤ Ϫ/Ϫ B6 donor mice have a preferential MHC-I-dependent reactivity. These data suggest that disease-associated CD4
ϩ T cells, raised in an MHC-II-dependent or MHC-II-independent way, differ in their restricted recognition pattern.
CD4 ϩ T cells from CD1d Ϫ/Ϫ KO B6 mice induced a colitis in RAG1
Ϫ/Ϫ hosts
MHC-II-independent CD4 ϩ T cells efficiently induced a colitis after transfer into RAG1
Ϫ/Ϫ hosts. CD1d-restricted and ␣-GalCerreactive NKT cells are the only well-characterized, MHC-II-independent CD4 ϩ T cell subset (27, 30, 46, 47) . In cLP CD4 ϩ T cell populations, we found NK1 ϩ T cells. cLP T cells from transplanted and diseased hosts did not respond to ␣-GalCer-pulsed CD1d ϩ DC (data not shown). This indicated that well-characterized CD1d-restricted NK1 ϩ CD4 ϩ T cells reactive to ␣-GalCer are not involved in IBD induction. This was confirmed in transfer experiments using CD4 ϩ T cells from CD1d Ϫ/Ϫ KO B6 donor mice. RAG1 Ϫ/Ϫ B6 hosts injected with purified, splenic CD4 ϩ T cells from CD1d Ϫ/Ϫ KO B6 mice developed a colitis (Fig. 2) . The time course of this disease, its histopathology, and the phenotype of the cLP CD4 ϩ T cells isolated from diseased RAG1 Ϫ/Ϫ resembled the IBD induced by transfer of normal B6 CD4 ϩ T cells (data not shown). Furthermore, transfer of CD4 ϩ T cells from J␣281 Ϫ/Ϫ KO B6 donor mice into RAG1 Ϫ/Ϫ B6 mice induced a colitis with a clinical course and histopathology similar to that induced by normal B6 CD4 ϩ T cells (data not shown). cLP CD4 ϩ T cells stimulated with lysate-pulsed DC from CD1d Ϫ/Ϫ B6 KO mice released IFN-␥ indicating that this MHC-I-like molecule is not involved (data not shown). In the last set of experiments, we transferred CD4 ϩ T cells from MHC-I-deficient ␤ 2 m Ϫ/Ϫ KO B6 mice into RAG1
Ϫ/Ϫ hosts to test whether MHC-I-dependent CD4 ϩ T cells are required to drive the disease process.
CD4 ϩ T cells from MHC-I-deficient ␤ 2 m Ϫ/Ϫ KO B6 donors induce no (or only very mild) colitis in RAG1
Ϫ/Ϫ KO hosts CD4 ϩ T cells were found in the spleen and cLP of MHC-I-deficient ␤ 2 m Ϫ/Ϫ KO B6 mice. After transfer into RAG1 Ϫ/Ϫ hosts, these cells induced no or only mild histopathological signs of colitis during a 10-to 16-wk observation period that were not accompanied by clinical signs (Fig. 2A) . Signs of a mild colitis were found only in 5/22 RAG1 Ϫ/Ϫ hosts transplanted with purified CD4 ϩ T cells from ␤ 2 m Ϫ/Ϫ KO B6 donor mice (Fig. 3F) ; the other hosts showed an essentially normal histology without signs of inflammation (Fig. 3A) . The surface phenotype of cLP CD4 ϩ from RAG1 Ϫ/Ϫ mice transplanted with T cells from ␤ 2 m Ϫ/Ϫ KO B6 donors was similar to that described above for cLP CD4 ϩ T cells from RAG1
Ϫ/Ϫ hosts transplanted with T cells from normal, MHC-II-deficient or CD1d-deficient B6 donor mice (Fig. 7A ). Striking differences were observed in the cytokine expression profile of cLP CD4 ϩ T cells from nondiseased RAG1 Ϫ/Ϫ hosts transplanted with CD4 ϩ T cells from MHC-I-deficient ␤ 2 m Ϫ/Ϫ KO B6 mice. Many of these T cells expressed IL-4 but few produced IFN-␥ or TNF-␣ (Fig. 7B) . This Th2-biased cytokine expression pattern is in contrast to the Th1-biased pattern described above for cLP CD4 ϩ T cells from RAG1 Ϫ/Ϫ B6 mice with colitis transplanted with CD4 ϩ T cells from normal B6, MHC-II-deficient (A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ ) B6, or CD1d Ϫ/Ϫ KO B6 mice. These data point to MHC-I/␤ 2 m-dependent (but not CD1d-restricted) CD4 ϩ T cells that promote the Th1-biased polarization of mucosal T cell responses in the colon.
Discussion
MHC-II-independent CD4
ϩ T cells are a heterogeneous populations of ␣␤ T cells. Their development seems to depend on conventional MHC-Ia molecules, MHC-Ib molecules (e.g., Qa-1), or CD1d molecules. Identification of MHC-II-independent CD4 ϩ T cell subsets is difficult with the currently available tools because no reliable markers are available to identify this CD4 ϩ T cell subsets. The NK1 marker is not expressed by all MHC-II-independent T cells, its expression is not stable (48) , and it is expressed on many activated, conventional CD4 ϩ and CD8 ϩ T cells in vivo (49, 50) .
ϩ T cells are present in the noninflamed intestinal mucosa. MHC-II-independent CD4
ϩ T cells were found in the intestinal lamina propria in A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ B6 mice.
The main finding of our study was the unexpected potency of MHC-II-independent CD4 ϩ T cells to induce colitis. CD4 ϩ T cells from either A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ KO B6 mice efficiently induced a colitis in congenic immunodeficient RAG1 Ϫ/Ϫ B6 hosts. This excludes the possibility that minor populations of MHC-II (A␣E␤)-dependent CD4 ϩ T cells from A␤ Ϫ/Ϫ KO mice can induce colitis or that minor histocompatibility differences between donor and host play a role (A␣ Ϫ/Ϫ KO mice were generated in B6 mice; A␤ Ϫ/Ϫ KO mice were from the 14th backcross to B6). The MHC-II-independent CD4 ϩ T cell subset that induced colitis is unknown. These T cells are present in normal, MHC-II Ϫ/Ϫ (A␣ 
subset of ϳ10
6 cells/organ in many lymphoid and nonlymphoid organs of the mouse. The majority of CD4 ϩ NKT cells are in vivo activated, rapidly release cytokines after stimulation, express intermediate levels of CD3 and TCR␣␤, and use an invariant V␣14J␣281 TCR ␣-chain (with an invariant CDR3 region containing no N-region additions/deletions) paired with V␤8.2, V␤7, or V␤2 (but not V␤5) TCR ␤-chains (with a variable CDR3 region). CD4
ϩ NKT cells recognize ␣-GalCer (25) (26) (27) (28) 30) in the context of CD1d (17, 24, 36) . In contrast to the restricted TCR V␣ and V␤ repertoire of CD1d-restricted, ␣-GalCer-specific CD4 ϩ NKT cells, other MHC-II-independent CD4 ϩ T cells show a diverse TCR␣␤ repertoire and do not recognize ␣-GalCer. CD4 ϩ T cells from A␣ Ϫ/Ϫ and A␤ Ϫ/Ϫ B6 donor mice that repopulated spleen, mesenteric lymph nodes, and gut mucosa of RAG1 Ϫ/Ϫ hosts showed a diverse TCR V␤ repertoire at an early stage of the disease, but a restricted TCR V␤ usage pattern as the disease progressed. (Fig. 7A) . The only striking difference observed was the cytokine expression profile of cLP CD4 ϩ T cells from transplanted RAG1 Ϫ/Ϫ mice. Although cLP CD4 ϩ T cells from diseased RAG1 Ϫ/Ϫ mice transplanted with T cells from normal, A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ B6 mice produced TNF-␣ and IFN-␥ but no IL-4, only few cLP CD4 ϩ T cells derived from ␤ 2 m Ϫ/Ϫ KO B6 mice produced TNF-␣ or IFN-␥ but many produced IL-4 and IL-10 (Fig. 7B) . The lack or very mild course of colitis, thus, coincided with a Th2-biased polarization of the T cell response in the cLP. A control of aggressive CD4 ϩ T cells (derived from CD45RB high precursors) by suppressive CD4 ϩ T cells (derived from CD45RB low precursors) in the pathogenesis of colitis has been proposed (3, 11, (51) (52) (53) (54) . A predominance of suppressive CD4 ϩ T cells in ␤ 2 m Ϫ/Ϫ B6 mice may explain the low incidence of colitis induction. When MHC-II-independent CD4 ϩ T cells (from A␤ Ϫ/Ϫ B6 mice) were either mixed to MHC-I-independent CD4 ϩ T cells (from ␤ 2 m Ϫ/Ϫ B6 mice) or transferred into disease-free RAG Ϫ/Ϫ hosts repopulated for 8 -14 wk with CD4 ϩ T cells from ␤ 2 m Ϫ/Ϫ donor B6 mice, a colitis developed (unpublished data). This argues against a dominant suppressive activity of CD4 ϩ T cells from ␤ 2 m Ϫ/Ϫ donor mice. It has been shown that IL-2 Ϫ/Ϫ ϫ ␤ 2 m Ϫ/Ϫ double KO mice spontaneously develop a CD4 ϩ T cell-dependent colitis (55) . In contrast to our data, MHC-II-dependent but not MHC-I-dependent CD4 ϩ T cells are critical for the development of colitis in this model. It has been reported that the transfer of 4 -5 ϫ 10 5 CD45RB high CD4 ϩ T cells into MHC-II Ϫ/Ϫ ϫ RAG Ϫ/Ϫ double KO hosts does not induce colitis (56) . This graft is expected to contain ϳ10 3 MHC-IIindependent CD4 ϩ T cells. In the absence of MHC-II-dependent CD4 ϩ T cells, this small number of transferred MHC-I-dependent CD4 ϩ T cells, thus, does not induce colitis. Alternatively, MHC- I-dependent CD4 ϩ T cells in A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ KO mice and in normal mice may differ.
We reported: 1) the efficient induction of IBD by CD4 ϩ ␣␤ T cells from either normal, CD1d
Ϫ/Ϫ and J␣281 Ϫ/Ϫ mice, or MHC-II-deficient (A␣ Ϫ/Ϫ or A␤ Ϫ/Ϫ ) mice; and 2) no (or inefficient) induction of IBD by CD4 ϩ ␣␤ T cells from MHC-I-deficient (␤ 2 m Ϫ/Ϫ ) mice. Therefore, dysregulation of T cell reactivity seems to be an important initiating event in the pathogenesis of colitis. We described three experimental conditions in which MHC-Iand/or MHC-II-dependent CD4 ϩ T cells were either present or absent (1) ϩ T cells expand polyclonally that do not induce IBD because they default to a Th2-biased reactivity (in the absence of regulatory MHC-II-independent CD4 ϩ T cells). MHC-I-dependent CD4 ϩ T cells, thus, seem to facilitate Th1-biased, mucosal CD4 ϩ T cell responses. A regulatory role of NKT cells has been proposed in the pathogenesis of graft-versus-host disease and autoimmune disease (57) (58) (59) . To our knowledge, we provide the first evidence that MHC-II-and CD1d-independent CD4 ϩ T cells can modulate the polarization of mucosal T cell responses in the gut.
